+1 (240) 387-9082
6000 Executive Blvd. # 101,
North Bethesda MD 28052
8am – 6pm
A life-changing journey with Bright Horizons—after decades of depression, I’ve found joy, connection, and hope. Grateful for the care, support, and transformation this experience has brought me.
Bright Horizons exceeded my expectations, guiding me from darkness to hope. With caring staff and effective treatment, I feel lighter, more positive, and on the path to recovery from depression.
After years of ineffective medications, TMS at Bright Horizons transformed my outlook. With compassionate care and painless treatments, I feel lighter, think differently, and highly recommend this!
About 70% of patients treated with Spravato® show a clinically meaningful response.
You'll take Spravato® twice a week for the first month and once a week for the second month.
Several major payers cover Spravato® treatment for depression.
and many more
Backed by science and most major health insurances
and many more
Treatment-resistant depression (TRD): This is depression that hasn’t improved after trying at least two different antidepressant medications.
Spravato is a brand-name nasal spray medication containing esketamine, which is a refined form of ketamine.
People with TRD or severe major depressive disorder (MDD) who haven’t seen improvement with other treatments like antidepressants and therapy.
It affects brain cells and increases glutamate production, potentially improving mood in ways that traditional antidepressants don’t.
Dr. Amir Etesam, MD, is a Johns Hopkins-trained Psychiatrist at Bright Horizons Psychiatry in North Bethesda, Maryland. After receiving his medical degree, Dr. Etesam chose to focus his career on mood and anxiety disorders. He is a member of the well-respected Alpha Omega Alpha (AOA), the only medical honor society in the world. Diagnostic clarification and appropriately treating psychiatric disorders are the fundamentals of Dr. Etesam’s practice and his promise to his patients.
His particular interests include complex psychopharmacology, Transcranial Magnetic Stimulation (TMS), and Intranasal Ketamine Esketamine (Spravato®) treatment. Dr. Etesam is a National Institute of Mental Health (NIH) certified TMS provider. At present, he sees and treats patients with mild to moderate depression, anxiety, bipolar disorder, OCD, and ADHD, including severe and treatment-resistant cases. He warmly welcomes all patients into Bright Horizons Psychiatry, and he looks forward to caring for them.
Psychiatrist and Medical Director
Nurse Practitioner
Nurse Practitioner
Head of Administration
Head of Neuromodulation
Office Manager
Esketamine Coordinator
TMS Coordinator
IM Ketamine Coordinator
Integrative Psychiatry Coordinator
Administrative Assistant
Spravato is FDA-approved—and it’s changing lives for people with depression that hasn’t responded to other treatments.
Depression shouldn’t cost you everything. With insurance coverage and financial guidance, getting better is possible—and affordable.
Relief without the rollercoaster—Spravato offers powerful results with minimal side effects.
Spravato is a nasal spray medication containing esketamine, a refined form of ketamine. It’s FDA-approved to treat treatment-resistant depression (TRD) and severe major depressive disorder (MDD) with suicidal thoughts or actions.
Spravato may be an option if you haven’t seen improvement with other treatments like antidepressants and therapy.
Many insurance plans cover Spravato, but coverage can vary. Check with your insurance provider to confirm.
Common side effects include sedation, dissociation, nausea, and increased blood pressure.
Spravato is a safe and effective treatment for TRD and MDD when used as prescribed. However, it’s important to discuss potential risks and benefits with your doctor.
Spravato works differently than traditional antidepressants. It affects brain cells and increases glutamate production, potentially improving mood.
We are here to support you in the healing journey
+1 (240) 387-9082
6000 Executive Blvd. # 101,
North Bethesda MD 28052
8am – 6pm